symmetric dimethylarginine has been researched along with Brain Vascular Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Choe, CU; Grosse, GM; Schwedhelm, E; Worthmann, H | 1 |
| Goniewicz, ML; Sobczak, A; Szoltysek-Boldys, I | 1 |
| Atzler, D; Benndorf, RA; Böger, RH; Darius, H; Diehm, C; Endres, HG; Lüneburg, N; Maas, R; Schwedhelm, E; Thiem, U; von Stritzky, B | 1 |
1 review(s) available for symmetric dimethylarginine and Brain Vascular Disorders
| Article | Year |
|---|---|
Arginine Derivatives in Cerebrovascular Diseases: Mechanisms and Clinical Implications.
Topics: Arginine; Biomarkers; Cerebrovascular Disorders; Endothelium, Vascular; Homoarginine; Humans; Nitric Oxide Synthase; Risk Factors | 2020 |
2 other study(ies) available for symmetric dimethylarginine and Brain Vascular Disorders
| Article | Year |
|---|---|
ADMA and SDMA levels in healthy men exposed to tobacco smoke.
Topics: Adolescent; Adult; Arginine; Cerebrovascular Disorders; Coronary Vessels; Humans; Male; Middle Aged; Nitric Oxide Synthase; Regression Analysis; Risk Factors; Smoking; Tobacco Smoke Pollution | 2009 |
Asymmetric dimethylarginine as an independent risk marker for mortality in ambulatory patients with peripheral arterial disease.
Topics: Aged; Arginine; Biomarkers; Cardiovascular Diseases; Cerebrovascular Disorders; Enzyme Inhibitors; Epidemiologic Methods; Female; Germany; Humans; Male; Nitric Oxide Synthase; Peripheral Arterial Disease; Prognosis | 2011 |